证券记录 · 已归档季度
CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
28被追踪持有人
+1Δ持有人
592.40M持有股份
$40.85B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +3.7% ·
股份流向 -0.2% ·
净新建仓位 +3.6%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 4.62M | $393.86M | +1 | n/a |
| Q2 2026 | 181 | +1 | 951.14M | $98.28B | +4 | −4 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | n/a |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | n/a | 197.40M | $11.65B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 122.69M | n/a | $8.46B | 0.2% | n/c | 1 | SEC ↗ ×23 |
| 2 | The Vanguard Group ✦ (被动) | 120.40M | n/a | $8.31B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 3 | Dodge & Cox ✦ | 73.29M | -0.2% | $5.06B | 2.8% | ▼ Trim | 5 | SEC ↗ |
| 4 | Capital World Investors ✦ | 66.96M | -2.1% | $4.62B | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 58.79M | +1.4% | $4.06B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 45.61M | n/a | $3.15B | 0.2% | n/c | 1 | SEC ↗ ×7 |
| 7 | Geode Capital Management ✦ (被动) | 28.64M | +2.4% | $1.97B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (被动) | 19.70M | +15.0% | $1.36B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 16.61M | +8.5% | $1.15B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Glenview Capital ✦ | 8.20M | -31.4% | $565.42M | 16.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 8.18M | +30.6% | $564.02M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 12 | Millennium Management ✦ | 4.07M | +9.1% | $280.52M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 3.11M | +153.0% | $214.24M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 14 | PRIMECAP Management ✦ | 2.93M | +0.4% | $202.07M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 15 | Fairfax Financial ✦ | 2.71M | 0.0% | $186.97M | 10.0% | Held | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 2.28M | -38.2% | $156.26M | 0.1% | ▼ Trim | 5 | SEC ↗ ×6 |
| 17 | Marshall Wace ✦ | 1.73M | -53.5% | $119.62M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 1.61M | +43.2% | $111.03M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 1.29M | +219.3% | $88.84M | 0.0% | ▲ Add | 5 | SEC ↗ ×8 |
| 20 | D. E. Shaw & Co. ✦ | 927.36K | +161.2% | $63.97M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 21 | Harris Associates (Oakmark) ✦ | 844.05K | -85.9% | $58.22M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 22 | Bridgewater Associates ✦ | 836.59K | +170.0% | $57.71M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 582.85K | +1065.7% | $40.21M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 176.39K | +19.5% | $12.17M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 131.78K | -2.4% | $9.09M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 94.11K | +1.0% | $6.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 22.69K | 0.0% | $1.57M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Tweedy, Browne ✦ | 5.06K | 新增 | $349,108 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Tweedy, Browne | $349,108 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,848 持有人, 1.07B 股份, $73.55B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据